Tweaking the gain on platelet regulation: the tachykinin connection

Atherosclerosis
Jonathan M Gibbins

Abstract

Soluble factors such as ADP and thromboxane (TX) A(2) that are secreted or released by platelets at sites of tissue injury, mediate autocrine and paracrine regulation of platelet function, resulting in rapid localised thrombus formation. The suppression of platelet function, particularly through targeting such secondary regulatory mechanisms, that serve to 'fine-tune' the platelet response, has proven effective in the prevention of inappropriate platelet activation that results in thrombosis. The most commonly used anti-platelet approaches (ADP receptor antagonism or inhibition of TXA(2) synthesis), however, lack efficacy in many patients, suggesting the existence of additional uncharacterised mechanisms for the regulation of platelet function. Recent data, which form a focus of this review, have identified peripheral tachykinin peptide family members, such as substance P and the newly identified endokinins, as physiologically important positive feedback regulators of platelet function. The actions of tachykinins that are released from platelets during activation are mediated by the neurokinin-1 receptor. Initial analysis of the role of this receptor in platelet thrombus formation, and thrombosis in the mouse, indicate this to ...Continue Reading

References

Nov 1, 1991·The Journal of Clinical Investigation·M H KrollA I Schafer
Apr 28, 1972·Nature·R I Hawkins
Jul 1, 1996·The International Journal of Biochemistry & Cell Biology·A M Khawaja, D F Rogers
Jan 1, 1996·Pharmacology & Therapeutics·R A Armstrong
Apr 16, 1998·Proceedings of the National Academy of Sciences of the United States of America·A ZimmerE Mezey
Jul 9, 1998·Journal of Neuroimmunology·J P LaiW Z Ho
Mar 17, 1999·The Journal of Clinical Investigation·M L KahnS R Coughlin
May 4, 1999·International Archives of Allergy and Immunology·A GecseG Telegdy
Aug 11, 2000·Diabetes Research and Clinical Practice·A B Sobol, C Watala
Oct 26, 2000·Neuropeptides·A LecciC A Maggi
Apr 27, 2001·Expert Opinion on Investigational Drugs·J Geiger
Jul 27, 2001·The American Journal of Cardiology·P A GumE J Topol
Nov 8, 2001·European Journal of Pharmacology·R Patacchini, C A Maggi
Mar 5, 2002·Nature Medicine·Patrick AndréDenisa D Wagner
May 31, 2002·Pharmacological Reviews·Cinzia SeveriniVittorio Erspamer
Sep 17, 2002·The Journal of Physiology·Andrew D GrantSusan D Brain
Oct 9, 2002·The Journal of Experimental Medicine·Steffen MassbergMeinrad Gawaz
Apr 30, 2003·Proceedings of the National Academy of Sciences of the United States of America·Nigel M PagePhilip J Lowry
Oct 4, 2003·Nature Reviews. Drug Discovery·Shaun P Jackson, Simone M Schoenwaelder
Dec 4, 2003·Expert Opinion on Pharmacotherapy·Lisa Patel, Celeste Lindley
May 8, 2004·Blood·Gwenda J GrahamJonathan M Gibbins
May 25, 2004·Expert Opinion on Emerging Drugs·Ruth A Duffy
Jun 19, 2004·Blood·Sanford J Shattil, Peter J Newman
Jul 15, 2004·Journal of Cell Science·Jonathan M Gibbins
Oct 27, 2004·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Stan HeptinstallRobert G Wilcox

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

Cell Adhesion Molecules in AS

Cell adhesion molecules expressed on the vascular endothelium and circulating leukocytes in response to inflammatory stimuli are implicated in atherosclerosis. Here is the latest research.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.